Amundi’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.44M | Buy |
404,436
+5,707
| +1% | +$62.6K | ﹤0.01% | 946 |
|
|
2025
Q1 | $3.99M | Buy |
398,729
+61,214
| +18% | +$613K | ﹤0.01% | 1011 |
|
|
2024
Q4 | $3.72M | Buy |
337,515
+44,019
| +15% | +$485K | ﹤0.01% | 1045 |
|
|
2024
Q3 | $3.31M | Buy |
293,496
+293,219
| +105,855% | +$3.31M | ﹤0.01% | 1060 |
|
|
2024
Q2 | $2.91K | Sell |
277
-231,294
| -100% | -$2.43M | ﹤0.01% | 1885 |
|
|
2024
Q1 | $2.4M | Buy |
231,571
+67,188
| +41% | +$696K | ﹤0.01% | 1113 |
|
|
2023
Q4 | $1.87M | Sell |
164,383
-195,354
| -54% | -$2.22M | ﹤0.01% | 1215 |
|
|
2023
Q3 | $3.63M | Buy |
359,737
+122,985
| +52% | +$1.24M | ﹤0.01% | 1043 |
|
|
2023
Q2 | $2.31M | Buy |
236,752
+211,391
| +834% | +$2.06M | ﹤0.01% | 1133 |
|
|
2023
Q1 | $180K | Buy |
25,361
+2,433
| +11% | +$17.3K | ﹤0.01% | 1593 |
|
|
2022
Q4 | $222K | Buy |
+22,928
| New | +$222K | ﹤0.01% | 1499 |
|